VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Aspire Biopharma Holdings, Inc. (ASBPW) Total Return Calculator with Dividends Reinvested

Aspire Biopharma Holdings, Inc.

Popular:

The total return for Aspire Biopharma Holdings, Inc. (ASBPW) stock is -66.22% over the past 12 months. So far it's down 18.28% this year. The 5-year total return is -81.90%, meaning $10,000 invested in ASBPW stock 5 years ago would be worth $1,810 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in ASBPW 1 year ago, it would be worth $3,378 today — you'd have lost $6,622.

With Dividends Reinvested$3,378-66.22%

Price Only (No DRIP)$3,378-66.22%

Period2025-05-08 → 2026-05-07

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in ASBPW

1Y$3,378-$6,622 (-66.2%)-66.2% CAGR

3Y$1,810-$8,190 (-81.9%)-43.4% CAGR

5Y$1,810-$8,190 (-81.9%)-29.0% CAGR

10Y$1,810-$8,190 (-81.9%)-15.7% CAGR

15Y$1,810-$8,190 (-81.9%)-10.8% CAGR

20Y$1,810-$8,190 (-81.9%)-8.2% CAGR

30Y$1,810-$8,190 (-81.9%)-5.5% CAGR

Aspire Biopharma Holdings, Inc. did not pay dividends during this period. Total return = price return.

Loading ASBPW total return...

As of 2026-05-08

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-18.28%	—	-18.28%	—	$8,172
1Y	-66.22%	-66.22%	-66.22%	—	$3,378
3Y	-81.90%	-43.44%	-81.90%	—	$1,810
5Y	-81.90%	-28.96%	-81.90%	—	$1,810
10Y	-81.90%	-15.71%	-81.90%	—	$1,810
15Y	-81.90%	-10.77%	-81.90%	—	$1,810
20Y	-81.90%	-8.19%	-81.90%	—	$1,810
30Y	-81.90%	-5.54%	-81.90%	—	$1,810

Risk & Highlights

Best Year-79.05%2025

Max Drawdown-84.19%2025-07-22 → 2026-04-01

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-3.23%	-3.23%	—	+0.41%	-3.6pp
2025	-79.05%	-79.05%	—	+16.64%	-95.7pp

ASBPW underperformed the S&P 500 by 96.59pp over the past year (-66.22% vs +30.37%).

Loading summary...

ASBPW Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
ASBPWAspire Biopharma Holdings, Inc.	$125,312	-1.9%	-18.3%	-66.2%	—	-81.9%	-81.9%	-81.9%
SNDLSNDL Inc.	$376M	+10.7%	-16.7%	+11.5%	—	-16.2%	-81.1%	-98.3%
GRWGGrowGeneration Corp.	$85M	+32.7%	-7.8%	+25.7%	—	-62.0%	-96.7%	-75.7%
IIPRInnovative Industrial Properties, Inc.	$1.6B	+13.3%	+18.3%	+20.3%	+14.2pp	+14.1%	-50.0%	+436.4%
ACBAurora Cannabis Inc.	$195M	+1.8%	-21.0%	-25.3%	—	-47.2%	-96.1%	-92.0%
HYFMHydrofarm Holdings Group, Inc.	$5M	+4.0%	-35.0%	-75.4%	—	-91.9%	-99.8%	-99.8%
LWAYLifeway Foods, Inc.	$391M	+12.6%	+12.5%	+6.1%	—	+327.3%	+427.0%	+167.1%
SGBXSafe & Green Holdings Corp.	$32,963	—	-52.9%	-96.3%	—	-99.8%	-100.0%	-100.0%
ATAIAtai Beckley N.V	$964M	+5.8%	+3.6%	+188.5%	—	+99.5%	-79.8%	-47.7%
CMPSCOMPASS Pathways plc	$902M	+69.5%	+43.4%	+151.1%	—	+11.0%	-72.4%	-67.6%
MNMDMind Medicine (MindMed) Inc.	$2.0B	—	+51.7%	+214.0%	—	+510.3%	-57.9%	+512.1%

Compare:ASBPW vs SNDL ASBPW vs GRWG ASBPW vs IIPR ASBPW vs SNDL vs GRWG

About ASBPW Dividend Returns

Aspire Biopharma Holdings, Inc. (ASBPW) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of ASBPW over the past year?

Aspire Biopharma Holdings, Inc. (ASBPW) delivered a return of -66.22% over the past year. Since ASBPW does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in ASBPW be worth today?

A $10,000 investment in Aspire Biopharma Holdings, Inc. one year ago would be worth $3,378 today, representing a loss of $6,622.

Q3Does ASBPW pay dividends?

Aspire Biopharma Holdings, Inc. (ASBPW) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For ASBPW, the total return equals the price-only return.

Q4Did ASBPW beat the S&P 500?

No, Aspire Biopharma Holdings, Inc. (ASBPW) underperformed the S&P 500 by 96.59 percentage points over the past year. ASBPW delivered a total return of -66.22%, compared to the S&P 500's 30.37%. This means a passive S&P 500 index fund outperformed ASBPW by 96.59pp during this period.

Q5What is ASBPW's worst drawdown?

Aspire Biopharma Holdings, Inc. (ASBPW) experienced a maximum drawdown of -84.19% over the past year, declining from its peak on 2025-07-22 to its trough on 2026-04-01. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is ASBPW's long-term total return over 10, 20, or 30 years?

Here are Aspire Biopharma Holdings, Inc. (ASBPW)'s long-term returns with dividends reinvested. Over 10 years, the total return is -81.9% (-15.7% CAGR) — $10,000 would have grown to $1,810. Over 20 years: -81.9% total return (-8.2% CAGR) — $10,000 → $1,810. Over 30 years: -81.9% total return (-5.5% CAGR) — $10,000 → $1,810. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.